Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...

A team of researchers in the US has conducted an initial experimental trial with 20 subjects to demonstrate that immunization ...

A new vaccine trial conducted on humans for pancreatic cancer, one of the deadliest malignancies in the world, showed immense ...

Pancreatic cancer specialists are excited about the biggest breakthrough in the field in decades. They are also looking ...

Pancreatic cancer can be a silent killer, especially for people who inherit mutant genes that greatly raise their risk for ...

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while sparing healthy tissue.

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

Researchers at Kanazawa University report the blood-based gene expression tests may enable early pancreatic cancer screening ...

A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

A phase 3 trial found daraxonrasib nearly doubled overall survival in previously treated metastatic pancreatic cancer. The ...

An experimental pill to treat metastatic pancreatic cancer almost doubled patients’ survival times compared with chemotherapy. The drug isn’t Food and Drug Administration approved, so it’s not readily ...